BloqBridge
Bloqcube
Contact Person:
Rama K Rao, Founder/CEO
rama@bloqcube.com
You may already be familiar with Bloqcube—a 2022 Prix Galien Startup Nominee in Digital Health—from its Clinical Trial Management & Financial System (CTMFS) platform. The blockchain-driven Decentralized Clinical Trials Platform was launched in Q4 2020 to aid with the timely resolution of clinical/budgetary/operational management issues during trial execution. More recently, the company built and tested a new blockchain-based Supply Chain Management (SCM) module called “BloqBridge,” as a part of its vision to lay the foundation for a Web3 platform.
The decentralized/hybrid trials environment has increased the number of sites to which investigational materials/kits need to be sent. In a paper by Rust Felix and Ethan Seville from SLOPE published in Applied Clinical Trials, they suggested that trials may need 65% to 85% more sites and are 75% over budget. Issues relating to “proper tracking/coordination” and “lost/spoiled biological samples” were among the key drivers for this. Their research also suggested that 87% of clinical inventory purchased for clinical trials is unused and discarded.
The BloqBridge module (built by their partner Copperwire), links an Internet of Things (IoT) device (manufactured by Tive) that is placed with the shipment, to Bloqcube’s blockchain-anchored system. It allows sponsors to geo-tag and track/monitor shipments for several parameters (e.g., temperature, humidity, light, and shock). Furthermore, the blockchain platform allows digital confirmation of provenance of the products shipped.
Ultimately, it permits sponsors to optimally manage product stock at the site and during transit, thereby potentially reducing waste. BloqBridge’s capabilities are particularly well suited for cell and gene therapy products especially for Chimeric Antigen Receptor-T cells therapies, where transparent, real-time tracking are deemed to be of utmost importance for ensuring safety and product quality.
